Thursday, October 8, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Business & M&AHugel chases 1 trillion won in three yearstodaySearch DemandMedical Spa Revenue Calculator: Model Your Practice Economics5 weeks agoBusiness & M&AAbbVie takes $216M charge on Q3 deals, cuts earnings2 days agoSearch DemandWho Can Inject Botox and Filler in Florida: Scope of Practice and Licensure Requirements5 weeks agoDevices & TechDEKA and GeoMedics expand laser portfolio across India3 days agoBusiness & M&AAbbVie Files Material Event: Botox/Juvéderm Pricing Shift5 weeks agoDevices & TechBTL expands EXOMIND brain stimulation to OCD, adolescents6 days agoDevices & TechHebei Zollvan Diode Laser Clears FDA 510(k)4 weeks agoDevices & TechSkinHealth Systems launches SkinStylus in six European marketslast weekDevices & TechVIOL Scarlet Pro Wins FDA 510(k) Clearance4 weeks agoRegulatoryAllergan gets Health Canada nod for Boey, a fast-acting short-duration toxinlast weekDevices & TechECHOLASER X4 Clears FDA 510(k) for General Surgery3 weeks ago
Brightening

Kojic Acid

Fungal-derived tyrosinase inhibitor that fades hyperpigmentation and dark spots.

Also known as: 5-hydroxy-2-hydroxymethyl-4H-pyran-4-one, kojic acid dipalmitate, Same name.

What it is
Kojic acid is a naturally occurring organic compound produced by certain fungi (notably Aspergillus and Acetobacter species) during fermentation. It's a small-molecule tyrosinase inhibitor that disrupts melanin synthesis at the enzyme level.
What it does
Kojic acid works by inhibiting tyrosinase, the enzyme responsible for converting the amino acid tyrosine into melanin. This reduces melanin production in melanocytes, leading to gradual fading of hyperpigmentation, age spots, melasma, and post-inflammatory hyperpigmentation. Results typically appear over 4–12 weeks of consistent use.
The evidence
Strong clinical evidence supports kojic acid's efficacy for melasma and post-inflammatory hyperpigmentation, with multiple controlled trials showing 20–40% improvement in pigmentation over 8–12 weeks. Moderate evidence exists for general brightening; it is less potent than hydroquinone but better tolerated.
Best for
Melasma, post-inflammatory hyperpigmentation, age spots, and uneven skin tone in all skin types, especially darker skin tones where irritation from stronger depigmenting agents is a concern.
Pairs well with
Niacinamide, vitamin C, glycolic acid, azelaic acid, and sunscreen (essential). Works synergistically with other tyrosinase inhibitors like arbutin or licorice extract.
Use cautiously with
Avoid combining with hydroquinone at high concentrations without professional guidance, as stacking depigmenting agents increases irritation risk. Use cautiously with strong exfoliants (retinoids, AHAs) in the same routine initially.
Cautions
Kojic acid can cause contact dermatitis and sensitization in 1–2% of users; patch test first. May increase photosensitivity slightly; daily SPF 30+ is mandatory. Generally safe in pregnancy, but consult a provider. Avoid if allergic to fungi or fermented products.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Get the free brief
Inside MedSpa · Free brief

By the time it's news, it's too late.

FDA decisions, recalls and the rules you operate under, drafted from the source documents and sent free by email.

Get the free brief The free Inside MedSpa brief · no card · unsubscribe anytime.
FDA, recalls and rule changes for practice owners Get the free brief →